OVERVIEW

The global E-prescription market is projected to reach USD 1619.5 million by 2024, rising over the forecast period at a CAGR of 19.8%. The market is driven by factors such as government initiatives and incentive programs, increasing focus on reducing fraud and abuse of controlled substances, and the need to curb escalating healthcare costs.

TABLE OF CONTENT

1 Global E-prescribing Market 

• 1.1 Study Objectives
• 1.2 Market Definition
• 1.3 Study Scope
  • 1.3.1 Markets Covered
  • 1.3.2 Geographic Scope

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global E-prescribing Market – Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global E-prescribing Market – Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global E-prescribing Market – Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis – Top 10 companies

• 6 Global E-prescribing Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global E-prescribing Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global E-prescribing Market – By Product (Market Size – & million/billion)
  • 8.1 Services
  • 8.2 Solutions

• 9 Global E-prescribing Market - By Delivery Mode
  • 9.1 Web & Cloud-based
  • 9.2 On-premise

• 10 Global E-prescribing Market - By End-User
  • 10.1 Hospitals
  • 10.2 Office-based Physicians
  • 10.3 Pharmaceuticals

• 11 Global E-prescribing Market – By Geography (Market Size – & million/billion)
  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 U.K
    • 11.3.2 Germany
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Rest of APAC
  • 11.5 Rest of the World
    • 11.5.1 South America
    • 11.5.2 Middle East
    • 11.5.3 Africa

• 12 Global E-prescribing Market – Entropy
  • 12.1 New product launches
  • 12.2 M&A's, collaborations, JVs and partnerships

• 13 Global E-prescribing Market Company Profile (Key Players)
  • 13.1 Market Share, Company Revenue, Products, M&A, Developments
  • 13.2 EPIC Systems Corporation
  • 13.3 Allscripts Healthcare Solutions
  • 13.4 Cerner Corporation
  • 13.5 Quality Systems, Inc.
  • 13.6 Relayhealth Corporation
  • 13.7 Computer Programs and Systems
  • 13.8 Surescripts-Rxhub, LLC
  • 13.9 Athenahealth, Inc.
  • 13.10 Medical Information Technology, Inc.
  • 13.11 Henry Schein, Inc.
  • 13.12 Company 11 & more

• 14 Global E-prescribing Market - Appendix
  • 14.1 Sources
  • 14.2 Abbreviations